X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (573) 573
humans (540) 540
definitive chemoradiotherapy (432) 432
oncology (422) 422
female (390) 390
male (383) 383
middle aged (381) 381
aged (376) 376
cancer (350) 350
esophageal cancer (339) 339
squamous-cell carcinoma (332) 332
surgery (328) 328
radiotherapy (323) 323
chemotherapy (319) 319
chemoradiotherapy (271) 271
treatment outcome (226) 226
retrospective studies (221) 221
adult (216) 216
radiation-therapy (190) 190
neoplasm staging (185) 185
care and treatment (182) 182
aged, 80 and over (177) 177
esophageal neoplasms - therapy (175) 175
chemoradiation (168) 168
esophageal neoplasms - pathology (168) 168
definitive radiotherapy (167) 167
prognosis (167) 167
carcinoma, squamous cell - therapy (158) 158
squamous cell carcinoma (157) 157
carcinoma, squamous cell - pathology (156) 156
survival (149) 149
radiology, nuclear medicine & medical imaging (137) 137
combined modality therapy (125) 125
radiation therapy (118) 118
survival rate (113) 113
analysis (108) 108
trial (108) 108
medicine & public health (107) 107
antineoplastic combined chemotherapy protocols - therapeutic use (106) 106
esophageal neoplasms - mortality (105) 105
carcinoma (104) 104
esophageal neoplasms - radiotherapy (104) 104
carcinoma, squamous cell - radiotherapy (103) 103
cisplatin (99) 99
carcinoma, squamous cell - mortality (96) 96
research (94) 94
esophageal neoplasms - drug therapy (91) 91
disease-free survival (90) 90
esophagus (90) 90
follow-up studies (88) 88
radiation (87) 87
esophageal squamous cell carcinoma (85) 85
radiotherapy dosage (85) 85
gastroenterology & hepatology (83) 83
patients (81) 81
carcinoma, squamous cell - drug therapy (79) 79
otorhinolaryngology (79) 79
cisplatin - administration & dosage (77) 77
therapy (77) 77
health aspects (75) 75
hematology, oncology and palliative medicine (73) 73
phase-ii (73) 73
chemoradiotherapy - methods (69) 69
phase-iii trial (69) 69
randomized-trial (69) 69
esophagectomy (68) 68
fluorouracil - administration & dosage (66) 66
tumors (66) 66
concurrent chemoradiotherapy (65) 65
carcinoma, squamous cell - surgery (64) 64
positron-emission-tomography (64) 64
survival analysis (64) 64
esophageal neoplasms - surgery (63) 63
metastasis (63) 63
toxicity (62) 62
surgical oncology (61) 61
cancer therapies (60) 60
lymphatic metastasis (60) 60
kaplan-meier estimate (58) 58
multivariate analysis (58) 58
salvage esophagectomy (56) 56
head and neck cancer (55) 55
definitive chemoradiation (53) 53
medical prognosis (52) 52
risk factors (52) 52
neck-cancer (50) 50
chemoradiotherapy - adverse effects (48) 48
induction chemotherapy (48) 48
quality-of-life (48) 48
salvage therapy (48) 48
5-fluorouracil (47) 47
neck dissection (47) 47
head and neck neoplasms - therapy (46) 46
patient outcomes (46) 46
usage (46) 46
cancer patients (45) 45
neoadjuvant chemoradiotherapy (45) 45
preoperative chemoradiotherapy (45) 45
abridged index medicus (44) 44
thoracic esophagus (44) 44
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Thoracic and Cardiovascular Surgery, ISSN 0022-5223, 06/2018, Volume 155, Issue 6, pp. 2710 - 2721.e3
Definitive chemoradiotherapy (CRT) remains the most commonly used treatment for locally advanced esophageal squamous cell carcinoma (SCC), because of... 
esophageal squamous cell carcinoma | pathological complete response | definitive chemoradiotherapy | esophagectomy, recurrence | trimodality treatment | neoadjuvant treatment | SURVIVAL | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | esophagectomy | CANCER | SALVAGE ESOPHAGECTOMY | recurrence | RESPIRATORY SYSTEM | CHEMORADIATION | EXPERIENCE
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 3, pp. 684 - 690
Purpose In this Phase II study, we evaluated the efficacy and toxicity of chemoradiotherapy (CRT) with cisplatin (CDDP) and 5-fluorouracil (5-FU) for Stage... 
Radiology | Hematology, Oncology and Palliative Medicine | Esophageal squamous cell carcinoma | Long-term toxicity | Salvage surgery | Chemoradiotherapy | SURGERY | SURVIVAL | THORACIC ESOPHAGUS | CANCER | CHEMOTHERAPY | SALVAGE ESOPHAGECTOMY | RADIATION-THERAPY | ONCOLOGY | CHEMORADIATION | RADIOTHERAPY | DEFINITIVE CHEMORADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Chemoradiotherapy - adverse effects | Age Factors | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Fluorouracil - administration & dosage | Esophageal Neoplasms - mortality | Adult | Female | Surveys and Questionnaires | Esophageal Neoplasms - therapy | Radiotherapy Dosage | Chemoradiotherapy - methods | Drug Administration Schedule | Carcinoma, Squamous Cell - therapy | Survival Rate | Remission Induction | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Health Status | Neoplasm Staging | Salvage Therapy - methods | Preoperative Care - methods | Medical colleges | Chemotherapy | Squamous cell carcinoma | Information services | Clinical trials | Esophageal cancer | Information services industry | Cisplatin | Cancer | Fluorouracil | Index Medicus | ESOPHAGUS | DIGESTIVE SYSTEM | COMPLEXES | HETEROCYCLIC COMPOUNDS | DEATH | INFUSION | MEDICINE | AZINES | ANTIMETABOLITES | FLUOROURACILS | IRRADIATION | ORGANIC HALOGEN COMPOUNDS | HYDROXY COMPOUNDS | THERAPY | DRUGS | RADIOLOGY AND NUCLEAR MEDICINE | PNEUMONITIS | ORGANIC NITROGEN COMPOUNDS | COMBINED THERAPY | RADIOLOGY | URACILS | NEOPLASMS | ORGANIC COMPOUNDS | ORGANIC FLUORINE COMPOUNDS | INTAKE | PYRIMIDINES | TOXICITY | SYMPTOMS | TRANSITION ELEMENT COMPLEXES | PLATINUM COMPLEXES | NUCLEAR MEDICINE | ORGANS | SURVIVAL TIME | DISEASES | CARCINOMAS | NAUSEA | BODY
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 7, pp. 627 - 637
Journal Article
Cancer Science, ISSN 1347-9032, 04/2015, Volume 106, Issue 4, pp. 407 - 412
Journal Article
Cancer Science, ISSN 1347-9032, 10/2015, Volume 106, Issue 10, pp. 1414 - 1420
We carried out a phase I/ II trial of chemoradiotherapy concurrent with S‐1 and cisplatin to determine the maximum tolerated dose and recommended dose and to... 
III | S‐1 | stage | cisplatin | esophageal carcinoma | Chemoradiotherapy | Esophageal carcinoma | Stage II/III | S-1 | Cisplatin | PLUS CISPLATIN | LOCAL FAILURE | stage II/III | ANTITUMOR-ACTIVITY | CANCER | RADIATION | IRRADIATION | THERAPY | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | DEFINITIVE CHEMORADIOTHERAPY | III TRIAL | Prospective Studies | Humans | Middle Aged | Male | Esophageal Neoplasms - radiotherapy | Carcinoma, Squamous Cell - radiotherapy | Young Adult | Pyridines - adverse effects | Adult | Female | Esophageal Neoplasms - therapy | Pyridines - therapeutic use | Radiotherapy Dosage | Chemoradiotherapy - methods | Tegafur - adverse effects | Tegafur - therapeutic use | Carcinoma, Squamous Cell - therapy | Treatment Outcome | Oxonic Acid - adverse effects | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Maximum Tolerated Dose | Oxonic Acid - therapeutic use | Carcinoma, Squamous Cell - drug therapy | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Cisplatin - adverse effects | Aged | Neoplasm Staging | Esophageal Neoplasms - drug therapy | Drug Combinations | Antimitotic agents | Chemotherapy | Carcinoma | Oncology, Experimental | Clinical trials | Product development | Research | Antineoplastic agents | Patient compliance | Esophageal cancer | Cancer | Index Medicus | stage II | Original
Journal Article
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 2013, Volume 14, Issue 6, pp. 3921 - 3924
Background: To investigate the role of surgical treatment for locally advanced esophageal cancer, we compared the outcomes of chemoradiotheroy alone (CRT) to... 
Iran | Postoperative chemo radiotherapy | Survival | Esophageal cancer | Definitive chemo radiotherapy | esophageal cancer | postoperative chemo radiotherapy | PROGNOSTIC-FACTORS | ONCOLOGY | survival
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 12/2017, Volume 22, Issue 6, pp. 1042 - 1049
Journal Article
Journal Article
Digestive Endoscopy, ISSN 0915-5635, 05/2018, Volume 30, Issue 3, pp. 338 - 346
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 46, pp. 80286 - 80294
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 4, pp. 1002 - 1007
Purpose To investigate the dose–volume histogram parameters and clinical factors as predictors of pleural effusion in esophageal cancer patients treated with... 
Radiology | Hematology, Oncology and Palliative Medicine | Heart | Pleural effusion | Chemoradiotherapy | Esophageal cancer | Dose–volume histogram | Dose-volume histogram | FIBROSIS | SURGERY | TOXICITY | RADIATION-THERAPY | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | TERM-FOLLOW-UP | PNEUMONITIS | RADIOTHERAPY | DEFINITIVE CHEMORADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Age Factors | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Male | Esophageal Neoplasms - radiotherapy | Esophageal Neoplasms - pathology | Pleural Effusion - pathology | Radiography | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Heart - radiation effects | Aged, 80 and over | Adult | Female | Lung - radiation effects | Aged | Combined Modality Therapy - methods | Retrospective Studies | Pleural Effusion - etiology | Esophageal Neoplasms - drug therapy | Esophageal Neoplasms - diagnostic imaging | Index Medicus | TOMOGRAPHY | ESOPHAGUS | PERFORMANCE | DIGESTIVE SYSTEM | LUNGS | METASTASES | RADIATION DOSES | MEDICINE | MATHEMATICS | MULTIVARIATE ANALYSIS | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | COMBINED THERAPY | DIAGNOSTIC TECHNIQUES | NEOPLASMS | STATISTICS | CARDIOVASCULAR SYSTEM | COMPUTERIZED TOMOGRAPHY | HEART | ORGANS | DISEASES | DOSES | RESPIRATORY SYSTEM | BODY | HAZARDS
Journal Article